Close Menu
    Facebook X (Twitter) Instagram
    Trending
    • Indian Institute of Technology Ropar Showcases Leadership Across Four Key Sessions at India AI Impact Summit 2026
    • PM Announces India–France National Centre of Excellence in Aviation at Kanpur under PM-SETU
    • AM Group Commences Development of Gigawatt Scale AI Compute Hub in Uttar Pradesh
    • From Boardrooms to Boundaries: Teams Light Up the Cricket Field
    • Raksha Mantri Inaugurates Missile Integration Facility At BEL
    • Prime Minister Welcomes Global Leaders to AI Impact Summit in Delhi
    • NHAI Accepts National Highways Infra Trust Offer To Acquire Two National Highway Assets
    • ONGC Reports A 1.6% Rise In Q3 Net Profit
    Facebook X (Twitter) YouTube
    Khabar India
    Khabar India Banner
    • Media Monitoring
    • National
    • BIHAR ELECTION
    • UP and States
    • Petroleum & Natural Gas
    • Private Sector
    • Infra
    • PSU
    • SKILL DEV./ CSR
    Khabar India
    You are at:Home » HPCL Is Top IIFL Pick Even As It Maintains Buy Rating On All 3 OMCs

    HPCL Is Top IIFL Pick Even As It Maintains Buy Rating On All 3 OMCs

    0
    By Aruna Sharma on October 13, 2017 PSU

    (FE)

    We upgrade FY18-19ii EPS for OMCs by 10-25% on the back of: 1) firm GRMs; 2) sustained product sales; and 3) strong outlook for marketing margins. OMCs trade inexpensively, offering earnings yield of 10-11% and dividend yield of 3.5-5% on FY18ii, assuming 40% payout (>45% in FY17). We maintain ‘buy’ on all the three OMCs. HPCL is our top pick, given its net long marketing portfolio and lowest embedded value in SoTP.

    We think that investor concerns on regulation on marketing margins seem unwarranted, given favourable policy changes and recent actions from the state and central governments such as the cut in VAT and excise duty respectively. OMCs should also gain from other products, including lubes and LPG. BPCL has the highest earnings upgrade over FY18ii/19ii. The company is adding 6 million MT capacity at Kochi and is expected to clock the highest earnings growth at 16-17% pa over FY18-20ii.

    We expect OMCs to maintain dividend payouts on the back of healthy cash flows and relatively underleveraged balance sheets through FY18-20ii. At CMP, a 40% payout implies dividend yield of 3.5- 5% for OMCs on FY18ii. Furthermore, on headline PE basis the stocks offer an average 10-11% earnings yield on FY18ii; valuations are compelling. We envisage rerating for the stocks, driven by consistent performance of the marketing division and as street acknowledges the pricing power of OMCs. We like all the three OMCs, and retain Buy.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Aruna Sharma

    Related Posts

    Indian Institute of Technology Ropar Showcases Leadership Across Four Key Sessions at India AI Impact Summit 2026

    PM Announces India–France National Centre of Excellence in Aviation at Kanpur under PM-SETU

    AM Group Commences Development of Gigawatt Scale AI Compute Hub in Uttar Pradesh

    • Facebook 99K
    • Twitter 1.5K
    • YouTube 370
    • Popular
    • Video
    • Pvt Sector
    February 27, 2026

    Indian Institute of Technology Ropar Showcases Leadership Across Four Key Sessions at India AI Impact Summit 2026

    February 19, 2026

    PM Announces India–France National Centre of Excellence in Aviation at Kanpur under PM-SETU

    February 16, 2026

    AM Group Commences Development of Gigawatt Scale AI Compute Hub in Uttar Pradesh

    July 23, 2025

    PM Narendra Modi Interacts With Media On The First Day Of Monsoon Session Of Parliament

    February 11, 2025

    Prime Minister Narendra Modi Gets A Rousing Welcome By Indian Community In Paris, France

    February 11, 2025

    Prime Minister Narendra Modi Attends Dinner Hosted By French President In Paris

    August 8, 2025

    Racing Towards Glory: Odisha Hosts the World Athletics Continental Tour Bronze

    August 6, 2025

    Hero MotoCorp Q1 Profit Surges 65% to ₹1,706 Crore on Ather Energy IPO Gains

    August 4, 2025

    Aurobindo Pharma Q1 FY26: Net Profit Falls 10% Despite Revenue Growth

    Company
    Company
    Recent Posts
    • Indian Institute of Technology Ropar Showcases Leadership Across Four Key Sessions at India AI Impact Summit 2026
    • PM Announces India–France National Centre of Excellence in Aviation at Kanpur under PM-SETU
    • AM Group Commences Development of Gigawatt Scale AI Compute Hub in Uttar Pradesh
    • From Boardrooms to Boundaries: Teams Light Up the Cricket Field
    • Raksha Mantri Inaugurates Missile Integration Facility At BEL
    • Media Monitoring
    • National
    • BIHAR ELECTION
    • UP and States
    • Petroleum & Natural Gas
    • Private Sector
    • Infra
    • PSU
    • SKILL DEV./ CSR
    Copyright © 2017 khabarindia.in. About / Privacy Policy / Terms and Condition / Contact Us

    Type above and press Enter to search. Press Esc to cancel.